Serial Number | 90798637 |
Word Mark | APOLLO THERAPEUTICS |
Filing Date | Monday, June 28, 2021 |
Status | 700 - REGISTERED |
Status Date | Tuesday, September 26, 2023 |
Registration Number | 7172183 |
Registration Date | Tuesday, September 26, 2023 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, April 11, 2023 |
Goods and Services | Education services, namely, providing instruction in the field of pharmaceutical and therapeutic medical education; arranging and conducting of conferences, congresses, courses, in particular in the fields of medicine and pharmaceuticals; publishing services, namely, the publication of periodicals, books, magazines, and articles in the field of medicine, pharmaceuticals, and therapeutics; publication of periodicals, books, magazines, articles, in particular in the fields of medicine, pharmaceuticals and therapeutics |
Goods and Services | Therapeutic pharmaceuticals for the treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases and disorders of the autoimmune system, allergies, renal transplant, hypertension, chronic kidney disease, and metabolic diseases; pharmaceutical preparations, namely biologics, biosimilars, small molecules, gene-engineered cell therapy in the nature of cells for medical use, namely autologous gene-engineered cells; medical preparations for the treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases and disorders of the autoimmune system, allergies, renal transplant, hypertension, chronic kidney disease, and metabolic diseases |
Goods and Services | Financial sponsorship in the form of providing financial resources to non-hospital partnerships, associations and companies, to aid in the research, development, production, import, export, retail, wholesale, promotion, commercial distribution and commercialisation of pharmaceutical, therapeutic and medicinal products and preparations |
Goods and Services | Collection of data and management of data for business purposes in connection with clinical research, testing, trial and development of pharmaceuticals, therapeutics and medical devices; computerized database management and data processing services in the field of medical, pharmaceutical and therapeutic treatment |
Goods and Services | Non-emergency and non-clinical medical and pharmaceutical consulting services related to the use of pharmaceutical preparations, namely biologics, biosimilars, small molecules, gene-engineered cell therapy and vaccines; non-emergency medical analysis services for diagnostic and treatment purposes related to the use of pharmaceutical preparations, namely biologics, biosimilars, small molecules, gene-engineered cell therapy and vaccines, provided by medical laboratories; medical analysis and examination services related to the treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases and disorders of the autoimmune system, allergies, renal transplant, hypertension, chronic kidney disease, and metabolic diseases, provided by medical laboratories; medical treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases and disorders of the autoimmune system, allergies, renal transplant, hypertension, chronic kidney disease, and metabolic diseases; advisory services relating to medical and pharmaceutical science, namely, medical advisory services and pharmaceutical advisory services in the field of the use of biologics, biosimilars, small molecules, gene-engineered cell therapy and vaccines for the treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases and disorders of the autoimmune system, allergies, renal transplant, hypertension, chronic kidney disease, and metabolic diseases |
Disclaimer with Predetermined Text | "THERAPEUTICS" |
Goods and Services | Scientific, medical and pharmaceutical research and development services; clinical research in the field of the use of biologics, biosimilars, small molecules, gene-engineered cell therapy and vaccines for the treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases and disorders of the autoimmune system, allergies, renal transplant, hypertension, chronic kidney disease, and metabolic diseases; pharmaceutical drug development services; scientific investigations for medical purposes; medical laboratory services; laboratory research services related to pharmaceuticals; advisory services relating to medical and pharmaceutical science research in the field of the use of biologics, biosimilars, small molecules, gene-engineered cell therapy and vaccines for the treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases and disorders of the autoimmune system, allergies, renal transplant, hypertension, chronic kidney disease, and metabolic diseases; research and development of pharmaceutical preparations |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, September 10, 2021 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 035 - Advertising; business management; business administration; office functions. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, March 1, 2023 |
Primary Code | 035 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Friday, September 10, 2021 |
Primary Code | 036 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
US Class Codes | 100, 101, 107 |
Class Status Code | 6 - Active |
Class Status Date | Friday, September 10, 2021 |
Primary Code | 041 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, September 10, 2021 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, September 10, 2021 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Apollo Therapeutics LLP |
Party Type | 30 - Original Registrant |
Legal Entity Type | 99 - Other |
Address | London SW72PG GB |
Party Name | Apollo Therapeutics LLP |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | London SW72PG GB |
Party Name | Apollo Therapeutics LLP |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | London SW72PG GB |
Event Date | Event Description |
Tuesday, September 26, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Tuesday, September 26, 2023 | REGISTERED-PRINCIPAL REGISTER |
Monday, August 21, 2023 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
Monday, July 10, 2023 | NOTICE OF ALLOWANCE CANCELLED |
Monday, August 21, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Monday, July 10, 2023 | TEAS DELETE 1(B) BASIS RECEIVED |
Tuesday, June 6, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, April 11, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, April 11, 2023 | PUBLISHED FOR OPPOSITION |
Wednesday, March 22, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Friday, March 3, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, March 1, 2023 | EXAMINER'S AMENDMENT ENTERED |
Wednesday, March 1, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Wednesday, March 1, 2023 | EXAMINERS AMENDMENT E-MAILED |
Wednesday, March 1, 2023 | EXAMINERS AMENDMENT -WRITTEN |
Tuesday, February 21, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, February 21, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, February 21, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, January 6, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, January 6, 2023 | NON-FINAL ACTION E-MAILED |
Friday, January 6, 2023 | NON-FINAL ACTION WRITTEN |
Thursday, November 10, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, November 9, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, November 9, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, August 30, 2022 | ASSIGNED TO EXAMINER |
Tuesday, June 7, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Tuesday, June 7, 2022 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
Tuesday, June 7, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Tuesday, June 7, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Thursday, June 2, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Thursday, June 2, 2022 | NON-FINAL ACTION E-MAILED |
Thursday, June 2, 2022 | NON-FINAL ACTION WRITTEN |
Friday, March 18, 2022 | ASSIGNED TO EXAMINER |
Friday, September 10, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Friday, August 6, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Friday, August 6, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Friday, August 6, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Thursday, July 1, 2021 | NEW APPLICATION ENTERED |